Attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia

Attractive Targeted Sugar Bait Phase III Trial Group, Thomas P Eisele, Immo Kleinschmidt, Sophie Sarrassat, Feiko terKuile, John Miller, Javan Chanda, Kafula Silumbe, Aaron Samuels, Julia Janssen, Caroline Ogwang, John Bradley, Erica Orange, Josh Yukich, Ruth Ashton, Irene Kyomuhangi, Angela F Harris, Seydou Doumbia, Mahamoudou Toure, Mohamed Moumine, Silas Majambere, Monicah Mirai Mburu, Gift Mwaanga, Limonty Simubali, Edgar Simulundu, Adam Bennett, Laurence Slutsker, Gunter Muller, Eric Ochomo, John Gimnig, Paul C D Johnson, Joseph Wagman, Megan Littrell, Attractive Targeted Sugar Bait Phase III Trial Group, Thomas P Eisele, Immo Kleinschmidt, Sophie Sarrassat, Feiko terKuile, John Miller, Javan Chanda, Kafula Silumbe, Aaron Samuels, Julia Janssen, Caroline Ogwang, John Bradley, Erica Orange, Josh Yukich, Ruth Ashton, Irene Kyomuhangi, Angela F Harris, Seydou Doumbia, Mahamoudou Toure, Mohamed Moumine, Silas Majambere, Monicah Mirai Mburu, Gift Mwaanga, Limonty Simubali, Edgar Simulundu, Adam Bennett, Laurence Slutsker, Gunter Muller, Eric Ochomo, John Gimnig, Paul C D Johnson, Joseph Wagman, Megan Littrell

Abstract

Background: Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) target night-time indoor biting mosquitoes and effectively reduce malaria transmission in rural settings across Africa, but additional vector control tools are needed to interrupt transmission. Attractive targeted sugar baits (ATSBs) attract and kill mosquitoes, including those biting outdoors. Deployment of ATSBs incorporating the insecticide dinotefuran was associated with major reductions in mosquito density and longevity in Mali. The impact of this promising intervention on malaria transmission and morbidity now needs to be determined in a range of transmission settings.

Methods/design: We will conduct three similar stand-alone, open-label, two-arm, cluster-randomized, controlled trials (cRCTs) in Mali, Kenya, and Zambia to determine the impact of ATSB + universal vector control versus universal vector control alone on clinical malaria. The trials will use a "fried-egg" design, with primary outcomes measured in the core area of each cluster to reduce spill-over effects. All household structures in the ATSB clusters will receive two ATSBs, but the impact will be measured in the core of clusters. Restricted randomization will be used. The primary outcome is clinical malaria incidence among children aged 5-14 years in Mali and 1-14 years in Kenya and Zambia. A key secondary outcome is malaria parasite prevalence across all ages. The trials will include 76 clusters (38 per arm) in Mali and 70 (35 per arm) in each of Kenya and Zambia. The trials are powered to detect a 30% reduction in clinical malaria, requiring a total of 3850 person-years of follow-up in Mali, 1260 person-years in Kenya, and 1610 person-years in Zambia. These sample sizes will be ascertained using two seasonal 8-month cohorts in Mali and two 6-month seasonal cohorts in Zambia. In Kenya, which has year-round transmission, four 6-month cohorts will be used (total 24 months of follow-up). The design allows for one interim analysis in Mali and Zambia and two in Kenya.

Discussion: Strengths of the design include the use of multiple study sites with different transmission patterns and a range of vectors to improve external validity, a large number of clusters within each trial site, restricted randomization, between-cluster separation to minimize contamination between study arms, and an adaptive trial design. Noted threats to internal validity include open-label design, risk of contamination between study arms, risk of imbalance of covariates across study arms, variation in durability of ATSB stations, and potential disruption resulting from the COVID-19 pandemic.

Trial registration: Zambia: ClinicalTrials.gov NCT04800055 . Registered on March 15, 2021 Mali: ClinicalTrials.gov NCT04149119 . Registered on November 4, 2019 Kenya: ClinicalTrials.gov NCT05219565 . Registered on February 2, 2022.

Keywords: Attractive targeted sugar bait; Cluster-randomized controlled trial; Malaria; Vector control.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Maps of each study site in Mali, Kenya, and Zambia
Fig. 2
Fig. 2
Photographs of the attractive targeted bait stations used in Mali, Kenya, and Zambia: A components of the ATSB, B a photograph of an installed ATSB in Zambia (November 2021)
Fig. 3
Fig. 3
Overview of the data collection plan in intervention and control areas

References

    1. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207–211. doi: 10.1038/nature15535.
    1. Ranson H, Lissenden N. Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control. Trends Parasitol. 2016;32(3):187–196. doi: 10.1016/j.pt.2015.11.010.
    1. Amek N, Bayoh N, Hamel M, Lindblade KA, Gimnig JE, Odhiambo F, et al. Spatial and temporal dynamics of malaria transmission in rural Western Kenya. Parasit Vectors. 2012;5:86. doi: 10.1186/1756-3305-5-86.
    1. Killeen GF, Marshall JM, Kiware SS, South AB, Tusting LS, Chaki PP, et al. Measuring, manipulating and exploiting behaviours of adult mosquitoes to optimise malaria vector control impact. BMJ Glob Health. 2017;2(2):e000212. doi: 10.1136/bmjgh-2016-000212.
    1. Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J. 2014;13:330. doi: 10.1186/1475-2875-13-330.
    1. Zhu L, Muller GC, Marshall JM, Arheart KL, Qualls WA, Hlaing WM, et al. Is outdoor vector control needed for malaria elimination? An individual-based modelling study. Malar J. 2017;16(1):266. doi: 10.1186/s12936-017-1920-y.
    1. Muller GC, Galili A. Attractive toxic sugar baits (ATSB): from basic science to product- a new paradigm for vector control. Westham; 2016. Available from:
    1. Lobo NF, Achee NL, Geico J, Collins FH. Malaria biology in the era of eradication PL. WDaA, editor. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2017. Modern vector control.
    1. Beier JC, Muller GC, Gu W, Arheart KL, Schlein Y. Attractive toxic sugar bait (ATSB) methods decimate populations of Anopheles malaria vectors in arid environments regardless of the local availability of favoured sugar-source blossoms. Malar J. 2012;11:31. doi: 10.1186/1475-2875-11-31.
    1. Traore MM, Junnila A, Traore SF, Doumbia S, Revay EE, Kravchenko VD, et al. Large-scale field trial of attractive toxic sugar baits (ATSB) for the control of malaria vector mosquitoes in Mali, West Africa. Malar J. 2020;19(1):72. doi: 10.1186/s12936-020-3132-0.
    1. Diarra RA, Traore MM, Junnila A, Traore SF, Doumbia S, Revay EE, et al. Testing configurations of attractive toxic sugar bait (ATSB) stations in Mali, West Africa, for improving the control of malaria parasite transmission by vector mosquitoes and minimizing their effect on non-target insects. Malar J. 2021;20(1):184. doi: 10.1186/s12936-021-03704-3.
    1. Marshall JM, White MT, Ghani AC, Schlein Y, Muller GC, Beier JC. Quantifying the mosquito’s sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control. Malar J. 2013;12:291. doi: 10.1186/1475-2875-12-291.
    1. Cross DE, Thomas C, McKeown N, Siaziyu V, Healey A, Willis T, et al. Geographically extensive larval surveys reveal an unexpected scarcity of primary vector mosquitoes in a region of persistent malaria transmission in western Zambia. Parasit Vectors. 2021;14(1):91. doi: 10.1186/s13071-020-04540-1.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Kibuchi E, Mitto B, Sang G, Kyalo D, Snow RW, Noor AM. An epidemiological profile of malaria in Mali. Nairobi: Kenya Medical Research Institute - Wellcome Trust Programme; 2015.
    1. Okara RM, Sinka ME, Minakawa N, Mbogo CM, Hay SI, Snow RW. Distribution of the main malaria vectors in Kenya. Malar J. 2010;9:69. doi: 10.1186/1475-2875-9-69.
    1. ICF INdlSIa . 2018 Mali demographic and health survey key findings. Rockville: INSTAT and ICF; 2019.
    1. Sovi A, Keita C, Sinaba Y, Dicko A, Traore I, Cisse MBM, et al. Anopheles gambiae (s.l.) exhibit high intensity pyrethroid resistance throughout Southern and Central Mali (2016–2018): PBO or next generation LLINs may provide greater control. Parasit Vectors. 2020;13(1):239. doi: 10.1186/s13071-020-04100-7.
    1. Ochomo E, Bayoh NM, Kamau L, Atieli F, Vulule J, Ouma C, et al. Pyrethroid susceptibility of malaria vectors in four districts of western Kenya. Parasit Vectors. 2014;7:310. doi: 10.1186/1756-3305-7-310.
    1. Thomsen EK, Strode C, Hemmings K, Hughes AJ, Chanda E, Musapa M, et al. Underpinning sustainable vector control through informed insecticide resistance management. PLoS One. 2014;9(6):e99822. doi: 10.1371/journal.pone.0099822.
    1. Fraser KJ, Mwandigha L, Traore SF, Traore MM, Doumbia S, Junnila A, et al. Estimating the potential impact of Attractive Targeted Sugar Baits (ATSBs) as a new vector control tool for Plasmodium falciparum malaria. Malar J. 2021;20(1):151. doi: 10.1186/s12936-021-03684-4.
    1. Bellissant E, Benichou J, Chastang C. A microcomputer program for the design and analysis of phase II cancer clinical trials with two group sequential methods, the sequential probability ratio test, and the triangular test. Comput Biomed Res. 1994;27(1):13–26. doi: 10.1006/cbmr.1994.1003.
    1. Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M, et al. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg. 2003;68(4 Suppl):121–127. doi: 10.4269/ajtmh.2003.68.121.
    1. Hayes RJ, Moulton LH. Cluster randomised trials. Statistics CI, editor. London: Chapman & Hall; 2009.
    1. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol. 1971;44(526):793–797. doi: 10.1259/0007-1285-44-526-793.
    1. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976;34(6):585–612. doi: 10.1038/bjc.1976.220.
    1. WHO . Norms, standards and processes underpinning development of WHO recommendations on vector control. Geneva: WHO; 2020.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren